NIPO trademark

ALNYLAM

RegisteredNIPOWord markClass 5

"ALNYLAM" is a word mark owned by Alnylam Pharmaceuticals, Inc., filed at the NIPO on July 31, 2018. It is registered and covers class 5 (Pharmaceuticals).

View Alnylam Pharmaceuticals, Inc. portfolioGet this data via the API
Official NIPO record
ALNYLAM
Word mark as filed with the NIPO
Status
Registered
Since January 11, 2019
Filed
July 31, 2018
Registered
January 11, 2019
Expires
July 31, 2028
Application no.
201810038
Registration no.
301867
Office
NIPO
Patentstyret (Norwegian Industrial Property Office)
Mark type
Word mark
1 class
Ownership

Who owns ALNYLAM

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alnylam Pharmaceuticals, Inc.

ALNY · Cambridge, United States

69 trademarks in the portfolioView company

Representative

Zacco Norway AS

Zacco Norway AS

Goods and services

What the mark covers

The products and services ALNYLAM is filed for, grouped by Nice class.

  • Farmasøytiske preparater, nemlig RNA terapeutiske legemidler for bruk i behandling av kreft, HIV, hepatitt A, hepatitt B, influensa, meslinger, nevrodegenerative sykdommer, transthyretin (TTR)- mediert amyloidose (ATTRR) [transthyretin (TTR)-mediated amyloidosis (ATTR)], hemofili, porfyri, komplement-mediert sykdom, hyperkolesterolemi, sjeldne genetiske syksommer, hjerte- og karsyksommer og stoffskiftesykdommer, hepatisk smittsomme sykdommer, arvelig ATTR amyloidose, sjeldne blødersykdommer, hepatiske porfyrier, alfa-1 antitrypsin-mangel, primær hyperoxaluri type 1, beta-thalassemi, sykdommer relatert til opphopning av jern, arvelig angioødem, hypertriglyceridemi, blandet hyperlipidemi, hypertriglyceridemi, hypertensjon, preeklampsi, tromboseprofylakse, hepatitt B virusinfeksjon, hepatitt D-virusinfeksjon, kronisk leverinfeksjon; farmasøytiske preparater, biosimilære produkter og biologiske preparater til medisinske og terapeutiske formål til anvendelse i behandlingen av kreft, HIV, hepatitt A, hepatitt B, influensa, meslinger, nevrodegenerative sykdommer, transthyretin (TTR)-mediert amyloidose (ATTRR) [transthyretin (TTR)-mediated amyloidosis (ATTR)], hemofili, porfyri, komplement-mediert lidelse, hyperkolesterolemi, sjeldne genetiske lidelser, hjerte- og karsykdommer og stoffskifteproblemer, hepatisk smittsomme sykdommer, arvelig ATTR amyloidose, sjeldne blødersykdommer, hepatiske porfyrier, alfa-1 antitrypsin-mangel, primær hyperoxaluri type 1, beta-thalassemi, sykdommer relatert til opphopning av jern, arvelig angioødem, hypertriglyceridemi, blandet hyperlipidemi, hypertriglyceridemi, hypertensjon, preeklampsi, tromboseprofylakse, hepatitt B virusinfeksjon, hepatitt D virusinfeksjon, kronisk leverinfeksjon; farmasøytiske preparater, nemlig RNA-terapeutiske legemidler; farmasøytiske preparater, biosimilære produkter og biologiske preparater til medisinske og terapeutiske formål.

History

What has happened so far

Steps recorded by the NIPO, newest first.

  1. Date of publication of a registered mark
FAQ

About ALNYLAM

Who owns the trademark "ALNYLAM"?

The NIPO trademark "ALNYLAM" (application 201810038) is owned by Alnylam Pharmaceuticals, Inc.

What is the status of "ALNYLAM"?

Its status at the NIPO is: registered.

When was "ALNYLAM" registered?

It was registered on January 11, 2019 and is due to expire on July 31, 2028.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ALNYLAM and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019e4bd9-5949-70cb-9bee-80fd7c53f4b5
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019e4bd9-5949-70cb-9bee-80fd7c53f4b5",
  "object": "trademark",
  "mark_text": "ALNYLAM",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "NO",
  "application_number": "201810038",
  "filing_date": "2018-07-31",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "ALNYLAM PHARMACEUTICALS, INC.",
      "entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
    }
  ]
}